Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A clinical trial of minocycline in lepromatous leprosy.

Literature DB >> 1737148

A clinical trial of minocycline in lepromatous leprosy.

R H Gelber¹, K Fukuda, S Byrd, L P Murray, P Siu, M Tsang, T H Rea.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Minocycline

Year: 1992 PMID： 1737148 PMCID： PMC1880969 DOI： 10.1136/bmj.304.6819.91

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

5 in total

1. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

Authors: J H Grosset; B H Ji; C C Guelpa-Lauras; E G Perani; L N N'Deli
Journal: Int J Lepr Other Mycobact Dis Date: 1990-06

2. Activity of minocycline in Mycobacterium leprae-infected mice.

Authors: R H Gelber
Journal: J Infect Dis Date: 1987-07 Impact factor: 5.226

3. A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.

Authors: C C Shepard
Journal: Lepr Rev Date: 1981-12 Impact factor: 0.537

4. Effect of low-level and intermittent minocycline therapy on the growth of Mycobacterium leprae in mice.

Authors: R H Gelber; P Siu; M Tsang; P Alley; L P Murray
Journal: Antimicrob Agents Chemother Date: 1991-05 Impact factor: 5.191

5. Experimental and clinical studies on rifampicin in treatment of leprosy.

Authors: R J Rees; J M Pearson; M F Waters
Journal: Br Med J Date: 1970-01-10

5 in total

17 in total

1. Another view of the therapy of leprosy.

Authors: R H Gelber
Journal: Antimicrob Agents Chemother Date: 1998-12 Impact factor: 5.191

2. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.

Authors: B Ji; S Sow; E Perani; C Lienhardt; V Diderot; J Grosset
Journal: Antimicrob Agents Chemother Date: 1998-05 Impact factor: 5.191

3. Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.

Authors: B Ji; P Jamet; E G Perani; S Sow; C Lienhardt; C Petinon; J H Grosset
Journal: Antimicrob Agents Chemother Date: 1996-09 Impact factor: 5.191

4. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.

Authors: B Ji; E G Perani; C Petinom; L N'Deli; J H Grosset
Journal: Antimicrob Agents Chemother Date: 1994-04 Impact factor: 5.191

A clinical trial of minocycline in lepromatous leprosy.

1. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

2. Activity of minocycline in Mycobacterium leprae-infected mice.

3. A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.

4. Effect of low-level and intermittent minocycline therapy on the growth of Mycobacterium leprae in mice.

5. Experimental and clinical studies on rifampicin in treatment of leprosy.

1. Another view of the therapy of leprosy.

2. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.

3. Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.

4. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.

5. Clinical trial of clarithromycin for lepromatous leprosy.

6. Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.

Review 7. Chemotherapy of lepromatous leprosy: recent developments and prospects for the future.

8. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.

9. Clinical trial of fusidic acid for lepromatous leprosy.

10. Powerful bactericidal activity of moxifloxacin in human leprosy.